Another drug made by a microscopic organism showed signs of becoming important last week. The Journal of the A.M.A. published an editorial on streptothricin, derived from Actinomyces lavendulae, a mold-like bacterium. Features of Streptothricin: 1) besides attacking many Gram-positive (blue-staining) bacteria, it attacks many of the Gram-negative (red-staining) against which penicillin is almost powerless—germs of typhoid, dysentery, etc.; 2) it is safe in therapeutic doses.
News from Rahway. When the new drug was quietly announced two years ago by Drs. Selman Abraham Waksman and Harold Boyd Woodruff of the New Jersey State...
To continue reading:
or
Log-In
